Schedule 13D ownership disclosure

CITIUS ONCOLOGY INC

Common Shares, $0.0001 par value per share · CUSIP: 17331Y109

Event date: 2025-07-17

Filing-level shares
66,049,615.00
Percent of class
84.3%
  • Citius Pharmaceuticals, Inc.Reported CIK 0001506251

    Shares: 66,049,615.00 · Class: 84.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-067797
Form type
SCHEDULE 13D/A
Filer
CITIUS ONCOLOGY, INC.
CIK
CIK 1851484
Filed
Jul 25, 2025
Reporting period
Jul 17, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub